GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zyden Gentec Ltd (BOM:530091) » Definitions » 3-Year ROIIC %

Zyden Gentec (BOM:530091) 3-Year ROIIC % : 0.00% (As of Mar. 2015)


View and export this data going back to 2000. Start your Free Trial

What is Zyden Gentec 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Zyden Gentec's 3-Year ROIIC % for the quarter that ended in Mar. 2015 was 0.00%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Zyden Gentec's 3-Year ROIIC % or its related term are showing as below:

BOM:530091's 3-Year ROIIC % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.29
* Ranked among companies with meaningful 3-Year ROIIC % only.

Zyden Gentec 3-Year ROIIC % Historical Data

The historical data trend for Zyden Gentec's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zyden Gentec 3-Year ROIIC % Chart

Zyden Gentec Annual Data
Trend Mar08 Mar09 Mar10 Mar11 Mar12 Mar13 Mar14 Mar15
3-Year ROIIC %
Get a 7-Day Free Trial - - - - -

Zyden Gentec Quarterly Data
Mar08 Mar09 Mar10 Mar11 Dec11 Mar12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
3-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Zyden Gentec's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Zyden Gentec's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zyden Gentec's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zyden Gentec's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Zyden Gentec's 3-Year ROIIC % falls into.



Zyden Gentec 3-Year ROIIC % Calculation

Zyden Gentec's 3-Year ROIIC % for the quarter that ended in Mar. 2015 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( 3.922 (Mar. 2015) - -30.8770881 (Mar. 2012) )/( 230.893 (Mar. 2015) - 252.101 (Mar. 2012) )
=34.7990881/-21.208
=-164.08%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Zyden Gentec  (BOM:530091) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Zyden Gentec 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Zyden Gentec's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zyden Gentec (BOM:530091) Business Description

Traded in Other Exchanges
N/A
Address
Kotri Road, 143/1, Deepshree Building, Gumanpura, Kota, RJ, IND, 324007
Zyden Gentec Ltd is an India based pharmaceutical company. It is principally engaged in manufacturing of pharmaceutical products and other allied activities. It manufactures drug intermediaries. The firm generates the majority of the revenue from the sale of its products. The company is located in the Indian state of Rajasthan.

Zyden Gentec (BOM:530091) Headlines

No Headlines